Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear

被引:65
作者
Wisman, GBA
Hollema, H
de Jong, S
ter Schegget, J
Tjong-A-Hung, SP
Ruiters, MHJ
Krans, M
de Vries, EGE
van der Zee, AGJ
机构
[1] Univ Groningen Hosp, Dept Gynecol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Pathol, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Med Oncol, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen Hosp, Biomed Technol Ctr, NL-9700 RB Groningen, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Virol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1200/JCO.1998.16.6.2238
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the diagnostic value of semiquantitative telomerase activity assessment in cervical scrapings together with human papillomavirus (HPV) typing for detection of (pre)neoplastic cervical lesions and to compare telomerase activity in cervical scrapings and frozen specimens from the same patients. Patients and Methods: A cross-sectional study was performed in 161 patients referred for an abnormal cervical cytology report. In cervical scrapings, telomerase activity was determined by modified telomere repeat amplification protocol (TRAP) assay and HPV typing by polymerase chain reaction (PCR) with general and type-specific primers. Final diagnosis was made by pathologic examination of biopsy and/or loop excision specimens. Results: Telomerase activity was detectable in assessable scrapings fram one of nine (11%) patients without cervical intraepitheleal neoplasia (CIN), in three of 26 (12%)with CIN I, eight of 35 (22%) with CIN II, 18 of 62 (29%) with CIN III, and four of 13 (31%) with cancer. Sensitivity and negative predictive value of the TRAP assay for CIN II/III and cancer lesions were 25% and 28%, respectively, while specificity for no CIN or CIN I was 89%. In representative frozen sections, frequency of detectable telomerase activity was related to grade of CIN/cancer; none of 21 normal cervices, none of two CIN I, two of 12 (17%) CIN II, 10 of 31 (32%) CIN III, and 18 of 21 (86%) cervical cancer lesions were telomerase-positive (P<.0005). Telomerase activity levels in paired scrapings and frozen sections appeared to be only weakly related; telomerase-positive sections with negative scrapings and vice versa (only in CIN III) were observed. In oncogenic HPV-negative scrapings (n = 14), no telomerase activity was detected, but in frozen sections, telomerase activity levels appeared to be unrelated to presence of specific HPV types. Conclusion: telomerase activity is more frequent in higher grade CIN/cervical cancer lesions. Telomerase activity assessment in cervical scrapings has a low sensitivity for CIN II/III and/or cervical cancer and does not appear to be useful in primary screening for cervical cancer. However, increased telomerase activity in frozen CIN sections may be a possible marker of progressive disease. (C) 1998 by American Society of Clinical Oncology.
引用
收藏
页码:2238 / 2245
页数:8
相关论文
共 45 条
[1]  
Anderson S, 1997, AM J PATHOL, V151, P25
[2]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[3]  
Bornstein J, 1995, Obstet Gynecol Surv, V50, P146, DOI 10.1097/00006254-199502000-00027
[4]   Telomerase and early detection of cancer: A National Cancer Institute workshop [J].
Breslow, RA ;
Shay, JW ;
Gazdar, AF ;
Srivastava, S .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) :618-623
[5]   PREDICTIVE VALUE OF HUMAN PAPILLOMAVIRUS TYPE FOR HISTOLOGICAL DIAGNOSIS OF WOMEN WITH CERVICAL CYTOLOGICAL ABNORMALITIES [J].
BURGER, MPM ;
HOLLEMA, H ;
PIETERS, WJLM ;
QUINT, WGV .
BRITISH MEDICAL JOURNAL, 1995, 310 (6972) :94-95
[6]   CIGARETTE-SMOKING AND HUMAN PAPILLOMAVIRUS IN PATIENTS WITH REPORTED CERVICAL CYTOLOGICAL ABNORMALITY [J].
BURGER, MPM ;
HOLLEMA, H ;
GOUW, ASH ;
PIETERS, WJLM ;
QUINT, WGV .
BRITISH MEDICAL JOURNAL, 1993, 306 (6880) :749-752
[7]  
Califano J, 1996, CANCER RES, V56, P5720
[8]   Clinical role of HPV testing [J].
Cox, JT .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1996, 23 (04) :811-+
[9]   HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING [J].
CUZICK, J ;
SZAREWSKI, A ;
TERRY, G ;
HO, L ;
HANBY, A ;
MADDOX, P ;
ANDERSON, M ;
KOCJAN, G ;
STEELE, ST ;
GUILLEBAUD, J .
LANCET, 1995, 345 (8964) :1533-1536
[10]   Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia [J].
deGruijl, TD ;
Bontkes, HJ ;
Walboomers, JMM ;
Schiller, JT ;
Stukart, MJ ;
Groot, BS ;
Chabaud, MMR ;
Remmink, AJ ;
Verheijen, RHM ;
Helmerhorst, TJM ;
Meijer, CJLM ;
Scheper, RJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) :630-638